Our partner Noze amplifies fight against tuberculosis with new grant MONTREAL, March 28, 2024 /PRNewswire/ — Canadian-based Noze, a global leader in the breath-based diagnostic space, announced today it received a new grant from the Bill & Melinda Gates Foundation, bringing the foundation’s total grant funding to Noze… Read More »Our partner Noze amplifies fight against tuberculosis with new grant
Article by Karim Aly, CEO of our partner Noze : Breath-based Analysis: Revolutionizing Disease Screening for a Healthier Tomorrow Despite significant progress in disease testing methodologies, notable deficiencies persist. Misdiagnosis, characterized by the detection of false positives, is prevalent across various screening procedures. Moreover, many severe… Read More »Article by Karim Aly, CEO of our partner Noze : Breath-based Analysis: Revolutionizing Disease Screening for a Healthier Tomorrow
The final video in the series developed by the project team is now available and explains the conduct of a clinical study Presented by Jessica Drouin, research nurse and coordinator at the Montreal Heart Institute, this video explains the steps related to the conduct of… Read More »The final video in the series developed by the project team is now available and explains the conduct of a clinical study
Our partner Noze announced the recruitment of the first participant in their breast cancer screening study with Dr. Meterissian of McGill 📣 We’re thrilled to announce the recruitment of the first participant in our breast cancer screening study in partnership with Dr. Sarkis Meterissian. Dr.… Read More »Our partner Noze announced the recruitment of the first participant in their breast cancer screening study with Dr. Meterissian of McGill
Our partner Ecogène-21, in collaboration with Delair, have successfully completed a medication delivery flight by drone over more than 150 km to help isolated patients (This article is available exclusively in French) Un drone de l’entreprise Delair, basée à Toulouse (Haute-Garonne), a effectué une livraison de… Read More »Our partner Ecogène-21, in collaboration with Delair, have successfully completed a medication delivery flight by drone over more than 150 km to help isolated patients
A short video is now available on the services offered by the MHI’s Beaulieu-Saucier Pharmacogenomics Center, a project partner https://www.youtube.com/watch?v=4yXc1RP8Jz4https://www.youtube.com/watch?v=SwkSqLjNies
The second video in the series developed by the project team is now available and explains what a clinical study is Also presented by Dr Guillaume Marquis-Gravel, this 2nd video explains in simple terms what a clinical study is and the concepts related to safety… Read More »The second video in the series developed by the project team is now available and explains what a clinical study is.
CBC radio show: Interview with Ecogène-21 – News on the drone delivery project (Interview is available exclusively in French) Résumé Au menu de l’émission : peut-on envisager une reconnaissance patrimoniale et historique du secteur de Port-Alfred semblable à celle du village historique de Val-Jalbert? Le citoyen Andy… Read More »CBC radio show: Interview with Ecogène-21 – News on the drone delivery project
Dr. Jean-Claude Tardif is the winner of the Michel Sarrazin Prize from the Club de Recherches Cliniques du Québec (CRCQ) Jean-Claude Tardif, Prix Michel-Sarrazin 2023 (This article is available exclusively in French) Remis depuis 1977, le prix Michel-Sarrazin honore une ou un scientifique québécois chevronné… Read More »Dr. Jean-Claude Tardif is the winner of the Michel Sarrazin Prize from the Club de Recherches Cliniques du Québec (CRCQ)
A short video has been developed by the project team to explain what research consent entails Presented by Dr. Guillaume Marquis-Gravel, cardiologist and researcher at the Montreal Heart Institute, this video defines the concepts of informed, voluntary, and ongoing consent. Additionally, it informs potential participants… Read More »A short video has been developed by the project team to explain what research consent entails